Arterial distensibility in Wegener's granulomatosis: A carotid-femoral pulse wave velocity study

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 3, 2007, Pages 281-285

  Yildiz, Mustafa ^a,b,e   Soy, Mehmet ^c   Kürüm, Turhan ^c   Yildiz, Şahin ^d  

^a SAKARYA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^e NONE   (Turkey)

Author keywords

Arterial distensibility; Inflammation; Pulse wave velocity; Wegener's granulomatosis

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; PREDNISOLONE;

ADULT; ANTHROPOMETRY; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; BLOOD VESSEL FUNCTION; CAROTID ARTERY; CASE CONTROL STUDY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMORAL ARTERY; HEMODYNAMICS; HUMAN; HYPOTHESIS; MALE; NON INVASIVE PROCEDURE; ONLINE ANALYSIS; PATIENT IDENTIFICATION; PULSE WAVE; RISK ASSESSMENT; WEGENER GRANULOMATOSIS;

BLOOD FLOW VELOCITY; BLOOD SEDIMENTATION; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PULSATILE FLOW; WEGENER GRANULOMATOSIS;

EID: 34648823388     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lamprecht P, Gross WL. Wegener's granulomatosis. Herz 2004; 29: 47-56.
2. Csernok E, Muller A, Gross WL. Immunopathology of ANCA-associated vasculitis. Intern Med 1999; 38: 759-65.
3. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994; 95: 244-50.
4. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114: 468-77.
5. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58: 249-61.
6. Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001; 14: 258S-63S.
7. Yildiz M, Soy M, Kürüm T, Özbay G. Increased pulse wave velocity and shortened pulse wave propagation time in young patients with rheumatoid arthritis. Can J Cardiol 2004; 20: 1097-100.
8. Imura R, Yamamoto K, Kanamori K, Mikami T, Yasuda H. Non invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 1986; 20: 208-14.
9. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
10. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
11. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-90.
12. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94.
13. Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P, Aromaa A. Heart rate and mortality. J Intern Med 2000; 247: 231-9.
14. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate - dependence of arterial distensibility in vivo. J Hypertens 1996; 14: 897-901.
15. Albaladejo P, Copie X, Boutouyrie P, Laloux B, Declere AD, Smulyan H. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension 2001; 38: 949-52.
16. Amann K, Neususs R, Ritz E, Irzyniec T, Wiest G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995; 8: 409-17.
17. Amann K, Wolf B, Nichols C, Torniq J, Schwarz U, Zeier M, et al. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997; 29: 770-5.
18. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59: 1834-41.
19. O'Rourke MF. Fundamentals of clinical cardiology: the arterial pulse in health and disease. Am Heart J 1971; 82: 687-702.
20. Armentano RL, Barra JG, Levenson J, Simon A, Pichel RH. Arterial wall mechanics in conscious dogs. Assessment of viscous, inertial, and elastic modules to characterize aortic wall behavior. Circ Res 1995; 76: 468-78.
21. Takami T, Shigemasa N. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-14.
22. Berthelot JM, Saraux A, Audrain M, Le Goff P, Hamidou M, Muller JY, et al. Poor predictive value of antinucleosome and antineutrophil cytoplasmic antibodies in a 270 inception cohort of patients with early naked arthritis of less than one year's duration. Ann Rheum Dis 2002; 61: 760-1.
23. Jennette JC, Falk RJ. Small-vessels vasculitis. N Engl J Med 1997; 337: 1512-23.
24. Reumaux D, Duthilleul P, Roos D. Pathogenesis of disease associated with antineutrophil cytoplasmic autoantibodies. Hum Immunol 2004; 65: 1-12.
25. de Leeuw K, Sanders J-S, Stegeman C, Smit A, Kallenberg CG, Bijl M. Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005; 64: 753-9.
26. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary artery disease: meta-analysis of prospective studies. JAMA 1998; 279: 1477-82.
27. Blaj S, Jurcut C, Jurcut R, Stanciu S, Suna C, Ciobica L, et al. Pulse pressure and inflammatory markers in apparently healthy premenopausal women. Rom J Intern Med 2003; 41: 125-35.
28. Jooss K, Yang Y, Wilson JM. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum Gene Ther 1996; 7: 1555-66.
29. Ratcliffe MA, Dawson AA. The effects of cardiotoxic chemotherapy on blood pressure in patients with lymphoma. Clin Lab Haematol 1998; 20: 353-6.